Teligent
TLGT
#10190
Rank
โ‚น1.46 B
Marketcap
โ‚น15.42
Share price
-13.85%
Change (1 day)
1,681.56%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Earnings for Teligent (TLGT)

Earnings in 2021 (TTM): -โ‚น3.24 Billion

According to Teligent's latest financial reports the company's current earnings are โ‚น46.29 Million. In 2020 the company made an earning of -โ‚น3.49 Billion a decrease over its 2019 earnings that were of -โ‚น0.73 Billion.

Earnings history for Teligent from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-โ‚น3.24 Billion-7.13%
2020-โ‚น3.49 Billion378.89%
2019-โ‚น0.73 Billion-46.87%
2018-โ‚น1.37 Billion10.47%
2017-โ‚น1.24 Billion-637.49%
2016โ‚น0.23 B-179.64%
2015-โ‚น0.29 Billion-181.72%
2014โ‚น0.35 B-4806.02%
2013-โ‚น7.53 Million-97.35%
2012-โ‚น0.29 Billion6.23%
2011-โ‚น0.27 Billion-18.59%
2010-โ‚น0.33 Billion-11.37%
2009-โ‚น0.38 Billion98.4%
2008-โ‚น0.19 Billion156.15%
2007-โ‚น73 Million-59.36%
2006-โ‚น0.18 Billion17.92%
2005-โ‚น0.16 Billion37.7%
2004-โ‚น0.12 Billion25.51%
2003-โ‚น88.15 Million-289.84%
2002โ‚น46.42 M-1605.88%
2001-โ‚น3.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น14.47 Billion 262.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.65 Billion-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA